Bausch + Lomb has announced that it has no immediate plans to go private, following an evaluation of...

Regeneron Pharmaceuticals has announced promising results from two major clinical trials—the Phase 3...

Pykus Therapeutics has announced it will present initial clinical data on PYK-2101, an investigation...

Lumenis Be. Ltd., a global leader in energy-based medical devices for eye care and aesthetics, has a...

EssilorLuxottica has received FDA medical device approval for its Nuance Audio Glasses, a groundbrea...

Qlaris Bio has announced positive topline results from two U.S. Phase 2 clinical trials—Osprey and A...

EyePoint Pharmaceuticals has announced positive 6-month results from its ongoing Phase 2 VERONA clin...

McKesson Corporation has signed a definitive agreement to acquire an 80 percent controlling interest...

Notal Vision has announced positive results from a pivotal study evaluating an artificial intelligen...

Beacon Therapeutics' laruparetigene zovaparvovec (laru-zova), a gene therapy for X-linked retinitis ...